Safety Study of Rituximab (Rituxan®) in Chronic Urticaria
Status:
Terminated
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
This study is being done to find out if a drug called Rituxan (Rituximab) is safe and
effective in treating people with chronic urticaria (hives) with persistent symptoms in spite
of taking antihistamines.